102 related articles for article (PubMed ID: 9182899)
1. Difficulties in the ascertainment of C9 deficiency: lessons to be drawn from a compound heterozygote C9-deficient subject.
Hobart MJ; Fernie BA; Würzner R; Oldroyd RG; Harrison RA; Joysey V; Lachmann PJ
Clin Exp Immunol; 1997 Jun; 108(3):500-6. PubMed ID: 9182899
[TBL] [Abstract][Full Text] [Related]
2. Genetic detection of the silent allele (*Q0) in hereditary deficiencies of the human complement C6, C7, and C9 components.
Alvarez V; Coto E; Setién F; Spath PJ; López-Larrea C
Am J Med Genet; 1995 Feb; 55(4):408-13. PubMed ID: 7762578
[TBL] [Abstract][Full Text] [Related]
3. A high incidence of C9 deficiency among healthy blood donors in Osaka, Japan.
Fukumori Y; Yoshimura K; Ohnoki S; Yamaguchi H; Akagaki Y; Inai S
Int Immunol; 1989; 1(1):85-9. PubMed ID: 2487678
[TBL] [Abstract][Full Text] [Related]
4. Molecular epidemiology of C9 deficiency heterozygotes with an Arg95Stop mutation of the C9 gene in Japan.
Kira R; Ihara K; Watanabe K; Kanemitsu S; Ahmed SU; Gondo K; Takeshita K; Hara T
J Hum Genet; 1999; 44(2):109-11. PubMed ID: 10083734
[TBL] [Abstract][Full Text] [Related]
5. The human complement C9 gene: identification of two mutations causing deficiency and revision of the gene structure.
Witzel-Schlömp K; Späth PJ; Hobart MJ; Fernie BA; Rittner C; Kaufmann T; Schneider PM
J Immunol; 1997 May; 158(10):5043-9. PubMed ID: 9144525
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity in the genetic basis of human complement C9 deficiency.
Witzel-Schlömp K; Hobart MJ; Fernie BA; Orren A; Würzner R; Rittner C; Kaufmann T; Schneider PM
Immunogenetics; 1998 Jul; 48(2):144-7. PubMed ID: 9634479
[No Abstract] [Full Text] [Related]
7. [C6, C7, C8 and C9].
Hatanaka M; Kitano E
Nihon Rinsho; 2010 Jun; 68 Suppl 6():90-3. PubMed ID: 20942009
[No Abstract] [Full Text] [Related]
8. Nonsense mutation in exon 4 of human complement C9 gene is the major cause of Japanese complement C9 deficiency.
Kira R; Ihara K; Takada H; Gondo K; Hara T
Hum Genet; 1998 Jun; 102(6):605-10. PubMed ID: 9703418
[TBL] [Abstract][Full Text] [Related]
9. Human peritoneal macrophages. Production in vitro of the active terminal complement components C5 to C9 and a functional alternative pathway of complement. Brief report.
Hetland G; Bungum L
APMIS; 1988 Jan; 96(1):89-92. PubMed ID: 3345254
[TBL] [Abstract][Full Text] [Related]
10. DNA polymorphisms and linkage relationship of the human complement component C6, C7, and C9 genes.
Coto E; Martínez-Naves E; Domínguez O; DiScipio RG; Urra JM; López-Larrea C
Immunogenetics; 1991; 33(3):184-7. PubMed ID: 1672663
[TBL] [Abstract][Full Text] [Related]
11. Meningococcal meningitis in a women with inherited deficiency of the ninth component of complement.
Fine DP; Gewurz H; Griffiss M; Lint TF
Clin Immunol Immunopathol; 1983 Sep; 28(3):413-7. PubMed ID: 6883811
[TBL] [Abstract][Full Text] [Related]
12. [Immunologic tests: C6, C7, C8 and C9].
Hatanaka M; Shimizu A
Nihon Rinsho; 2005 Jul; 63 Suppl 7():92-4. PubMed ID: 16111197
[No Abstract] [Full Text] [Related]
13. Inhibition of immune haemolysis by a serum factor found in C3-deficient subjects.
Kitamura H; Tsuboi M
Immunology; 1989 Feb; 66(2):264-9. PubMed ID: 2925225
[TBL] [Abstract][Full Text] [Related]
14. A biotin-avidin sandwich ELISA for quantification of intact complement component C9. The sera from hereditary C9 deficient individuals completely lack C9.
Takata Y; Moriyama T; Fukumori Y; Yoden A; Shima M; Inai S
J Immunol Methods; 1989 Feb; 117(1):107-13. PubMed ID: 2913155
[TBL] [Abstract][Full Text] [Related]
15. Membrane factors responsible for homologous species restriction of complement-mediated lysis: evidence for a factor other than DAF operating at the stage of C8 and C9.
Shin ML; Hänsch G; Hu VW; Nicholson-Weller A
J Immunol; 1986 Mar; 136(5):1777-82. PubMed ID: 2419414
[TBL] [Abstract][Full Text] [Related]
16. Studies on the mechanism of bacterial resistance to complement-mediated killing. II. C8 and C9 release C5b67 from the surface of Salmonella minnesota S218 because the terminal complex does not insert into the bacterial outer membrane.
Joiner KA; Hammer CH; Brown EJ; Frank MM
J Exp Med; 1982 Mar; 155(3):809-19. PubMed ID: 6801180
[TBL] [Abstract][Full Text] [Related]
17. Hereditary complement (C9) deficiency associated with dermatomyositis.
Ichikawa E; Furuta J; Kawachi Y; Imakado S; Otsuka F
Br J Dermatol; 2001 May; 144(5):1080-3. PubMed ID: 11359403
[TBL] [Abstract][Full Text] [Related]
18. Reference typing report for complement components C6, C7 and C9 including mutations leading to deficiencies.
Würzner R; Witzel-Schlömp K; Tokunaga K; Fernie BA; Hobart MJ; Orren A
Exp Clin Immunogenet; 1998; 15(4):268-85. PubMed ID: 10072638
[TBL] [Abstract][Full Text] [Related]
19. An abnormal but functionally active complement component C9 protein found in an Irish family with subtotal C9 deficiency.
Orren A; O'Hara AM; Morgan BP; Moran AP; Würzner R
Immunology; 2003 Mar; 108(3):384-90. PubMed ID: 12603605
[TBL] [Abstract][Full Text] [Related]
20. Recurrent meningitis in a patient with congenital deficiency of the C9 component of complement. First case of C9 deficiency in Europe.
Zoppi M; Weiss M; Nydegger UE; Hess T; Späth PJ
Arch Intern Med; 1990 Nov; 150(11):2395-9. PubMed ID: 2241452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
